Freezing of gait, or FOG, is said to affect approximately 7% of individuals with early Parkinson’s disease (PD) and more than half of those with advanced PD.1This is due to the loss of postural reflexes, which are automatic movements that help us maintain equilibrium and balance when we are standing upright. FOG is usually defined as an onset of not being able to start stepping forward, with no apparent cause, and can be exacerbated by stress or distraction.1 FOG can look like trembling of the legs, shortening of steps or shuffling, or feeling like one is unable to move their feet.2 It’s one of the most debilitating aspects of PD and can increase fall risk. While there is no known cure for this, there are potential treatments for it, and ways to prevent FOG are being explored.
Market Analysis and Insights: Global Freezing of Gait Treatment Market
The global Freezing of Gait Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Freezing of Gait Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Freezing of Gait Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Freezing of Gait Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Freezing of Gait Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Freezing of Gait Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Freezing of Gait Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Segment by Type
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Segment by Application
Hospitals
Clinics
Research and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Freezing of Gait Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Freezing of Gait Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Freezing of Gait Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Freezing of Gait Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Dopaminergic Medication
1.2.3 Wearable and Walking Aid Devices
1.2.4 Deep Brain Stimulation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Freezing of Gait Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research and Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Freezing of Gait Treatment Market Perspective (2019-2030)
2.2 Global Freezing of Gait Treatment Growth Trends by Region
2.2.1 Freezing of Gait Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Freezing of Gait Treatment Historic Market Size by Region (2019-2024)
2.2.3 Freezing of Gait Treatment Forecasted Market Size by Region (2025-2030)
2.3 Freezing of Gait Treatment Market Dynamics
2.3.1 Freezing of Gait Treatment Industry Trends
2.3.2 Freezing of Gait Treatment Market Drivers
2.3.3 Freezing of Gait Treatment Market Challenges
2.3.4 Freezing of Gait Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Freezing of Gait Treatment by Players
3.1.1 Global Freezing of Gait Treatment Revenue by Players (2019-2024)
3.1.2 Global Freezing of Gait Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Freezing of Gait Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Freezing of Gait Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Freezing of Gait Treatment Market Concentration Ratio
3.4.1 Global Freezing of Gait Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Freezing of Gait Treatment Revenue in 2023
3.5 Global Key Players of Freezing of Gait Treatment Head office and Area Served
3.6 Global Key Players of Freezing of Gait Treatment, Product and Application
3.7 Global Key Players of Freezing of Gait Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Freezing of Gait Treatment Breakdown Data by Type
4.1 Global Freezing of Gait Treatment Historic Market Size by Type (2019-2024)
4.2 Global Freezing of Gait Treatment Forecasted Market Size by Type (2025-2030)
5 Freezing of Gait Treatment Breakdown Data by Application
5.1 Global Freezing of Gait Treatment Historic Market Size by Application (2019-2024)
5.2 Global Freezing of Gait Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Freezing of Gait Treatment Market Size (2019-2030)
6.2 North America Freezing of Gait Treatment Market Size by Type
6.2.1 North America Freezing of Gait Treatment Market Size by Type (2019-2024)
6.2.2 North America Freezing of Gait Treatment Market Size by Type (2025-2030)
6.2.3 North America Freezing of Gait Treatment Market Share by Type (2019-2030)
6.3 North America Freezing of Gait Treatment Market Size by Application
6.3.1 North America Freezing of Gait Treatment Market Size by Application (2019-2024)
6.3.2 North America Freezing of Gait Treatment Market Size by Application (2025-2030)
6.3.3 North America Freezing of Gait Treatment Market Share by Application (2019-2030)
6.4 North America Freezing of Gait Treatment Market Size by Country
6.4.1 North America Freezing of Gait Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Freezing of Gait Treatment Market Size by Country (2019-2024)
6.4.3 North America Freezing of Gait Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Freezing of Gait Treatment Market Size (2019-2030)
7.2 Europe Freezing of Gait Treatment Market Size by Type
7.2.1 Europe Freezing of Gait Treatment Market Size by Type (2019-2024)
7.2.2 Europe Freezing of Gait Treatment Market Size by Type (2025-2030)
7.2.3 Europe Freezing of Gait Treatment Market Share by Type (2019-2030)
7.3 Europe Freezing of Gait Treatment Market Size by Application
7.3.1 Europe Freezing of Gait Treatment Market Size by Application (2019-2024)
7.3.2 Europe Freezing of Gait Treatment Market Size by Application (2025-2030)
7.3.3 Europe Freezing of Gait Treatment Market Share by Application (2019-2030)
7.4 Europe Freezing of Gait Treatment Market Size by Country
7.4.1 Europe Freezing of Gait Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Freezing of Gait Treatment Market Size by Country (2019-2024)
7.4.3 Europe Freezing of Gait Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Freezing of Gait Treatment Market Size (2019-2030)
8.2 China Freezing of Gait Treatment Market Size by Type
8.2.1 China Freezing of Gait Treatment Market Size by Type (2019-2024)
8.2.2 China Freezing of Gait Treatment Market Size by Type (2025-2030)
8.2.3 China Freezing of Gait Treatment Market Share by Type (2019-2030)
8.3 China Freezing of Gait Treatment Market Size by Application
8.3.1 China Freezing of Gait Treatment Market Size by Application (2019-2024)
8.3.2 China Freezing of Gait Treatment Market Size by Application (2025-2030)
8.3.3 China Freezing of Gait Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Freezing of Gait Treatment Market Size (2019-2030)
9.2 Asia Freezing of Gait Treatment Market Size by Type
9.2.1 Asia Freezing of Gait Treatment Market Size by Type (2019-2024)
9.2.2 Asia Freezing of Gait Treatment Market Size by Type (2025-2030)
9.2.3 Asia Freezing of Gait Treatment Market Share by Type (2019-2030)
9.3 Asia Freezing of Gait Treatment Market Size by Application
9.3.1 Asia Freezing of Gait Treatment Market Size by Application (2019-2024)
9.3.2 Asia Freezing of Gait Treatment Market Size by Application (2025-2030)
9.3.3 Asia Freezing of Gait Treatment Market Share by Application (2019-2030)
9.4 Asia Freezing of Gait Treatment Market Size by Region
9.4.1 Asia Freezing of Gait Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Freezing of Gait Treatment Market Size by Region (2019-2024)
9.4.3 Asia Freezing of Gait Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Freezing of Gait Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Acorda Therapeutics
11.1.1 Acorda Therapeutics Company Details
11.1.2 Acorda Therapeutics Business Overview
11.1.3 Acorda Therapeutics Freezing of Gait Treatment Introduction
11.1.4 Acorda Therapeutics Revenue in Freezing of Gait Treatment Business (2019-2024)
11.1.5 Acorda Therapeutics Recent Developments
11.2 The Michael J. Fox Foundation
11.2.1 The Michael J. Fox Foundation Company Details
11.2.2 The Michael J. Fox Foundation Business Overview
11.2.3 The Michael J. Fox Foundation Freezing of Gait Treatment Introduction
11.2.4 The Michael J. Fox Foundation Revenue in Freezing of Gait Treatment Business (2019-2024)
11.2.5 The Michael J. Fox Foundation Recent Developments
11.3 GYENNO
11.3.1 GYENNO Company Details
11.3.2 GYENNO Business Overview
11.3.3 GYENNO Freezing of Gait Treatment Introduction
11.3.4 GYENNO Revenue in Freezing of Gait Treatment Business (2019-2024)
11.3.5 GYENNO Recent Developments
11.4 MedEXO Robotics
11.4.1 MedEXO Robotics Company Details
11.4.2 MedEXO Robotics Business Overview
11.4.3 MedEXO Robotics Freezing of Gait Treatment Introduction
11.4.4 MedEXO Robotics Revenue in Freezing of Gait Treatment Business (2019-2024)
11.4.5 MedEXO Robotics Recent Developments
11.5 TABLE Teva Pharmaceuticals
11.5.1 TABLE Teva Pharmaceuticals Company Details
11.5.2 TABLE Teva Pharmaceuticals Business Overview
11.5.3 TABLE Teva Pharmaceuticals Freezing of Gait Treatment Introduction
11.5.4 TABLE Teva Pharmaceuticals Revenue in Freezing of Gait Treatment Business (2019-2024)
11.5.5 TABLE Teva Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Ěý
Ěý
*If Applicable.
